203 related articles for article (PubMed ID: 36897372)
1. Alleviation of cholestatic liver injury and intestinal permeability by lubiprostone treatment in bile duct ligated rats: role of intestinal FXR and tight junction proteins claudin-1, claudin-2, and occludin.
Safari F; Sharifi M; Talebi A; Mehranfard N; Ghasemi M
Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):2009-2022. PubMed ID: 36897372
[TBL] [Abstract][Full Text] [Related]
2. Electroacupuncture Ameliorates Intestinal Barrier Destruction in Mice With Bile Duct Ligation-Induced Liver Injury by Activating the Cholinergic Anti-Inflammatory Pathway.
Lei W; Zhao C; Sun J; Jin Y; Duan Z
Neuromodulation; 2022 Dec; 25(8):1122-1133. PubMed ID: 35300921
[TBL] [Abstract][Full Text] [Related]
3. Chronic stress and intestinal permeability: Lubiprostone regulates glucocorticoid receptor-mediated changes in colon epithelial tight junction proteins, barrier function, and visceral pain in the rodent and human.
Zong Y; Zhu S; Zhang S; Zheng G; Wiley JW; Hong S
Neurogastroenterol Motil; 2019 Feb; 31(2):e13477. PubMed ID: 30284340
[TBL] [Abstract][Full Text] [Related]
4. Lubiprostone Induces Claudin-1 and Protects Intestinal Barrier Function.
Nishii N; Oshima T; Li M; Eda H; Nakamura K; Tamura A; Ogawa T; Yamasaki T; Kondo T; Kono T; Tozawa K; Tomita T; Fukui H; Miwa H
Pharmacology; 2020; 105(1-2):102-108. PubMed ID: 31536982
[TBL] [Abstract][Full Text] [Related]
5. The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats.
Verbeke L; Farre R; Verbinnen B; Covens K; Vanuytsel T; Verhaegen J; Komuta M; Roskams T; Chatterjee S; Annaert P; Vander Elst I; Windmolders P; Trebicka J; Nevens F; Laleman W
Am J Pathol; 2015 Feb; 185(2):409-19. PubMed ID: 25592258
[TBL] [Abstract][Full Text] [Related]
6. Bile duct ligation in the rat causes upregulation of ZO-2 and decreased colocalization of claudins with ZO-1 and occludin.
Maly IP; Landmann L
Histochem Cell Biol; 2008 Mar; 129(3):289-99. PubMed ID: 18197414
[TBL] [Abstract][Full Text] [Related]
7. IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats.
Zhao TY; Su LP; Ma CY; Zhai XH; Duan ZJ; Zhu Y; Zhao G; Li CY; Wang LX; Yang D
BMC Gastroenterol; 2015 Jul; 15():77. PubMed ID: 26152281
[TBL] [Abstract][Full Text] [Related]
8. Blood-Brain Barrier Permeability Is Exacerbated in Experimental Model of Hepatic Encephalopathy via MMP-9 Activation and Downregulation of Tight Junction Proteins.
Dhanda S; Sandhir R
Mol Neurobiol; 2018 May; 55(5):3642-3659. PubMed ID: 28523565
[TBL] [Abstract][Full Text] [Related]
9. Effects of Bile Duct Ligation and Ghrelin Treatment on the Colonic Barrier and Microbiome of Mice.
Ehlers L; Netz LAW; Reiner J; Berlin P; Bannert K; Bastian M; Zechner D; Lamprecht G; Jaster R
Pharmacology; 2022; 107(11-12):564-573. PubMed ID: 36327953
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway.
Abdel-Rahman N; Sharawy MH; Megahed N; El-Awady MS
Toxicol Appl Pharmacol; 2019 Oct; 380():114697. PubMed ID: 31394158
[TBL] [Abstract][Full Text] [Related]
11. Bile canalicular barrier function and expression of tight-junctional molecules in rat hepatocytes during common bile duct ligation.
Takakuwa Y; Kokai Y; Sasaki K; Chiba H; Tobioka H; Mori M; Sawada N
Cell Tissue Res; 2002 Feb; 307(2):181-9. PubMed ID: 11845325
[TBL] [Abstract][Full Text] [Related]
12. Melatonin exerts a therapeutic effect on cholestatic liver injury in rats with bile duct ligation.
Ohta Y; Kongo M; Kishikawa T
J Pineal Res; 2003 Mar; 34(2):119-26. PubMed ID: 12562503
[TBL] [Abstract][Full Text] [Related]
13. The Protective Effect of Heme Oxygenase-1 against Intestinal Barrier Dysfunction in Cholestatic Liver Injury Is Associated with NF-κB Inhibition.
Zhang L; Zhang Z; Liu B; Jin Y; Tian Y; Xin Y; Duan Z
Mol Med; 2017 Oct; 23():215-224. PubMed ID: 28805232
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nitric oxide synthesis during induced cholestasis ameliorates hepatocellular injury by facilitating S-nitrosothiol homeostasis.
López-Sánchez LM; Corrales FJ; Barcos M; Espejo I; Muñoz-Castañeda JR; Rodríguez-Ariza A
Lab Invest; 2010 Jan; 90(1):116-27. PubMed ID: 19806079
[TBL] [Abstract][Full Text] [Related]
15. Empagliflozin Exhibits Hepatoprotective Effects Against Bile Duct Ligation-induced Liver Injury in Rats: A Combined Molecular Docking Approach to In Vivo Studies.
Shakerinasab N; Azizi M; Mansourian M; Sadeghi H; Salaminia S; Abbasi R; Shahaboddin ME; Doustimotlagh AH
Curr Pharm Des; 2022; 28(40):3313-3323. PubMed ID: 36305136
[TBL] [Abstract][Full Text] [Related]
16. Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms.
Quinn M; McMillin M; Galindo C; Frampton G; Pae HY; DeMorrow S
Dig Liver Dis; 2014 Jun; 46(6):527-34. PubMed ID: 24629820
[TBL] [Abstract][Full Text] [Related]
17. Modulation of transport and metabolism of bile acids and bilirubin by chlorogenic acid against hepatotoxicity and cholestasis in bile duct ligation rats: involvement of SIRT1-mediated deacetylation of FXR and PGC-1α.
Zhu L; Wang L; Cao F; Liu P; Bao H; Yan Y; Dong X; Wang D; Wang Z; Gong P
J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):195-205. PubMed ID: 29360226
[TBL] [Abstract][Full Text] [Related]
18. Effect of Rifaximin on Hepatic Fibrosis in Bile Duct-ligated Rat Model.
Shin SK; Kwon OS; Lee JJ; Park YH; Choi CS; Jeong SH; Choi DJ; Kim YS; Kim JH
Korean J Gastroenterol; 2017 Nov; 70(5):239-246. PubMed ID: 29161793
[TBL] [Abstract][Full Text] [Related]
19. Oleanolic acid attenuates obstructive cholestasis in bile duct-ligated mice, possibly via activation of NRF2-MRPs and FXR antagonism.
Chen P; Li J; Fan X; Zeng H; Deng R; Li D; Huang M; Bi H
Eur J Pharmacol; 2015 Oct; 765():131-9. PubMed ID: 26297978
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of the roots extract of Platycodon grandiflorum on bile duct ligation-induced hepatic fibrosis in rats.
Lim JH; Kim TW; Song IB; Park SJ; Kim MS; Cho ES; Jung JY; Son HY; Kim JW; Yun HI
Hum Exp Toxicol; 2013 Nov; 32(11):1197-205. PubMed ID: 23424213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
